Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin versus parallel saline infusion to prevent local thromboembolic complications during continuous factor VIII infusion
NL-OMON23399Recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Sep 2009
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of heparin, sodium chloride and Factor VIII in hemophilia A (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Lifespan of intra venous catheter. Started Sep 2009; status: recruiting.
02
Drugs
heparinsodium chlorideFactor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NL-OMON23399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23399.